全文获取类型
收费全文 | 419552篇 |
免费 | 29080篇 |
国内免费 | 6230篇 |
专业分类
耳鼻咽喉 | 5549篇 |
儿科学 | 8650篇 |
妇产科学 | 10645篇 |
基础医学 | 58072篇 |
口腔科学 | 12708篇 |
临床医学 | 35506篇 |
内科学 | 84037篇 |
皮肤病学 | 8993篇 |
神经病学 | 29319篇 |
特种医学 | 15545篇 |
外国民族医学 | 102篇 |
外科学 | 64803篇 |
综合类 | 17405篇 |
现状与发展 | 16篇 |
一般理论 | 70篇 |
预防医学 | 20203篇 |
眼科学 | 10584篇 |
药学 | 35358篇 |
26篇 | |
中国医学 | 4933篇 |
肿瘤学 | 32338篇 |
出版年
2021年 | 4603篇 |
2020年 | 3326篇 |
2019年 | 4128篇 |
2018年 | 6030篇 |
2017年 | 4829篇 |
2016年 | 4793篇 |
2015年 | 5954篇 |
2014年 | 8157篇 |
2013年 | 9493篇 |
2012年 | 13101篇 |
2011年 | 13567篇 |
2010年 | 8231篇 |
2009年 | 7539篇 |
2008年 | 11593篇 |
2007年 | 12482篇 |
2006年 | 12390篇 |
2005年 | 11268篇 |
2004年 | 10416篇 |
2003年 | 10291篇 |
2002年 | 9776篇 |
2001年 | 29496篇 |
2000年 | 29877篇 |
1999年 | 24858篇 |
1998年 | 5988篇 |
1997年 | 5012篇 |
1996年 | 4296篇 |
1995年 | 4041篇 |
1994年 | 3595篇 |
1993年 | 3085篇 |
1992年 | 16323篇 |
1991年 | 15057篇 |
1990年 | 14372篇 |
1989年 | 14127篇 |
1988年 | 12755篇 |
1987年 | 12171篇 |
1986年 | 11199篇 |
1985年 | 10381篇 |
1984年 | 6960篇 |
1983年 | 5618篇 |
1982年 | 2727篇 |
1979年 | 5480篇 |
1978年 | 3347篇 |
1977年 | 2963篇 |
1975年 | 2636篇 |
1974年 | 3064篇 |
1973年 | 2863篇 |
1972年 | 2828篇 |
1971年 | 2773篇 |
1970年 | 2510篇 |
1969年 | 2544篇 |
排序方式: 共有10000条查询结果,搜索用时 251 毫秒
71.
Xiaoli Wang Yangyang Cheng Jing Shi Xiangyun Sheng Dan Wu Yali Zhao 《Acta oto-laryngologica》2020,140(2):116-121
AbstractBackground: Auditory steady-state response (ASSR) and click-evoked auditory brain response (c-ABR) have been used for hearing assessment for decades years, the correlation of the two methods and the effects of type and degree of hearing loss (HL) to the correlation in infants younger than 6?months of age are unclear.Objectives: To compare the correlation of ASSR and c-ABR and then to analyse the effects of type and degree of HL on the correlation in infants younger than 6?months of age.Material and methods: Retrospective study comparing ASSR thresholds at various frequencies with c-ABR thresholds. 182 ears from 96 infants were assessed and classified according to types and degrees of HL.Results: The correlation coefficients were: 0.823, 0.864, 0.891, 0.871, 0.908, 0.915 and 0.913 between ASSR thresholds at 0.5, 1, 2, 4, 2–4, 1–2–4, 0.5–1–2–4?kHz and c-ABR thresholds respectively. The correlation coefficients in the group of sensorineural HL (SHL) (r?=?0.763–0.900) were higher than conductive HL (r?=?0.309–0.619) across all frequencies. The coefficients of severe-profound SHL (r?=?0.595–0.790) were higher than mild-moderate SHL (r?=?0.434–0.687) across all frequencies.Conclusions and significance: ASSR was one valuable cross-check measure by providing frequency specific information in auditory assessment. 相似文献
72.
目的 探讨慕课在我国高等医学教育领域的应用现状和发展趋势,为本领域今后的研究提供参考。方法 检索中国知网、万方数据服务平台、维普数据库、中国生物医学文献数据库建库以来至2020年3月1日收录的相关文献,运用文献计量学方法对年发文量、期刊分布、基金支持、著者分布、被引频次、文献类型和高频关键词进行统计分析。将导出的资料用Excel 2010建立数据库,借助频数分析法进行描述性统计。结果 纳入文献754篇,分别收录于262种期刊;以医学教育类期刊为主;基金资助率达50%;黄坪、张欣、李鑫辉等7人为核心作者;以人体解剖学为代表的基础医学类课程应用研究最多;慕课应用研究以理论课程为主;课程评价包括终末性评价、形成性评价、平台考核、综合能力和自主学习能力5大方面;研究热点为基于慕课的混合式教学模式及其在护理教育、中医教育及继续医学教育中的应用。结论 近5年,慕课在我国高等医学教育中发展迅速,核心作者已形成,但缺乏深度合作。未来应增加实验(训)类课程的应用研究,同时应进一步完善实验性研究的设计及课程评价体系。 相似文献
73.
74.
Parallel enzyme‐linked immunosorbent assay screening for human immunodeficiency virus among blood donors in five Chinese blood centres: a retrospective analysis 下载免费PDF全文
75.
76.
77.
78.
Apatinib, an oral small molecular receptor tyrosine kinase inhibitor (TKI) developed first in China, exerts antiangiogenic and antineoplastic function through selectively binding and inhibiting vascular endothelial growth
factor receptor 2 (VEGFR-2). In this study, we aimed to explore the efficacy and safety profile of apatinib
monotherapy, or combined with chemotherapy or endothelial growth factor receptor (EGFR)-TKI in heavily
pretreated non-small cell lung cancer (NSCLC) patients with brain metastases. We performed a retrospective
analysis for relapsed NSCLC patients with brain metastases from our institute, who received apatinib
(250 mg or 500 mg p.o. qd) monotherapy, or combination with EGFR-TKI or chemotherapy as second or
more line systemic therapy until disease progression or unacceptable toxicity occurred. The objective response
rate (ORR), disease control rate (DCR), median progression-free survival (mPFS), median overall survival
(mOS), and safety were analyzed. A total of 26 eligible patients were included: 24 patients diagnosed with
adenocarcinoma, 2 with squamous carcinoma, and 14 patients harboring EGFR sensitizing mutations. The
mPFS and mOS were 4.93 (range, 0.27−32.91; 95% CI 3.64−6.22) and 14.70 (range, 0.27−32.91; 95% CI
0.27−43.60) months for the whole group. The ORR and DCR were 7.7% (2/26) and 69.2% (18/26) for the
entire lesions, and 7.7% (2/26) and 79.6% (20/26) for brain metastases, respectively. Compared with patients
who received apatinib monotherapy, patients who received apatinib combination treatment had more favorable
mPFS (11.77 vs. 2.27 months, p<0.05) and mOS (24.03 vs. 6.07 months, p<0.05). Treatment-related toxicities
were tolerable including grade 1/2 hypertension, hand-and-foot syndrome, fatigue, nausea, liver dysfunction,
myelosuppression, skin rash, and palpitation. In conclusion, apatinib exhibited high activity and good tolerance
for NSCLC patients with brain metastasis, and it might become a potential choice for metastatic brain tumors
in NSCLC patients. 相似文献
79.
Harinakshi Sanikini David C. Muller Marisa Sophiea Sabina Rinaldi Antonio Agudo Eric J. Duell Elisabete Weiderpass Kim Overvad Anne Tjønneland Jytte Halkjær Marie-Christine Boutron-Ruault Franck Carbonnel Iris Cervenka Heiner Boeing Rudolf Kaaks Tilman Kühn Antonia Trichopoulou Georgia Martimianaki Anna Karakatsani Valeria Pala Domenico Palli Amalia Mattiello Rosario Tumino Carlotta Sacerdote Guri Skeie Charlotta Rylander María-Dolores Chirlaque López Maria-Jose Sánchez Eva Ardanaz Sara Regnér Tanja Stocks Bas Bueno-de-Mesquita Roel C.H. Vermeulen Dagfinn Aune Tammy Y.N. Tong Nathalie Kliemann Neil Murphy Marc Chadeau-Hyam Marc J. Gunter Amanda J. Cross 《International journal of cancer. Journal international du cancer》2020,146(4):929-942
Obesity has been associated with upper gastrointestinal cancers; however, there are limited prospective data on associations by subtype/subsite. Obesity can impact hormonal factors, which have been hypothesized to play a role in these cancers. We investigated anthropometric and reproductive factors in relation to esophageal and gastric cancer by subtype and subsite for 476,160 participants from the European Prospective Investigation into Cancer and Nutrition cohort. Multivariable hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox models. During a mean follow-up of 14 years, 220 esophageal adenocarcinomas (EA), 195 esophageal squamous cell carcinomas, 243 gastric cardia (GC) and 373 gastric noncardia (GNC) cancers were diagnosed. Body mass index (BMI) was associated with EA in men (BMI ≥30 vs. 18.5–25 kg/m2: HR = 1.94, 95% CI: 1.25–3.03) and women (HR = 2.66, 95% CI: 1.15–6.19); however, adjustment for waist-to-hip ratio (WHR) attenuated these associations. After mutual adjustment for BMI and HC, respectively, WHR and waist circumference (WC) were associated with EA in men (HR = 3.47, 95% CI: 1.99–6.06 for WHR >0.96 vs. <0.91; HR = 2.67, 95% CI: 1.52–4.72 for WC >98 vs. <90 cm) and women (HR = 4.40, 95% CI: 1.35–14.33 for WHR >0.82 vs. <0.76; HR = 5.67, 95% CI: 1.76–18.26 for WC >84 vs. <74 cm). WHR was also positively associated with GC in women, and WC was positively associated with GC in men. Inverse associations were observed between parity and EA (HR = 0.38, 95% CI: 0.14–0.99; >2 vs. 0) and age at first pregnancy and GNC (HR = 0.54, 95% CI: 0.32–0.91; >26 vs. <22 years); whereas bilateral ovariectomy was positively associated with GNC (HR = 1.87, 95% CI: 1.04–3.36). These findings support a role for hormonal pathways in upper gastrointestinal cancers. 相似文献
80.